SIA
BMY.RT

Sit Investment Associates’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Sit Investment Associates’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,485
Closed -$12K – 552
2020
Q4 		$12K Sell
17,485
-850
-5% -$1.81K ﹤0.01% 517
2020
Q3 		$41K Hold
18,335
– – ﹤0.01% 500
2020
Q2 		$66K Hold
18,335
– – ﹤0.01% 497
2020
Q1 		$70K Hold
18,335
– – ﹤0.01% 496
2019
Q4 		$55K Buy
+18,335
New +$47.7K ﹤0.01% 497

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Sit Investment Associates's BMY.RT Position: Q1 2021 in Review

Sit Investment Associates sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 17,485 shares — an estimated $12K sold.

Sit Investment Associates first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $70K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Sit Investment Associates reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Sit Investment Associates sold 17,485 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $12K.
  • Sit Investment Associates first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Sit Investment Associates's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $70K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sit Investment Associates's 13F filing for Q1 2021, filed 13 May 2021.